Resolution of primary acquired melanosis with atypia after minimal mitomycin C treatment
Article first published online: 18 DEC 2007
Clinical & Experimental Ophthalmology
Volume 35, Issue 9, pages 865–867, December 2007
How to Cite
Chen, J. Y., Chappell, A. J., Klebe, S. and Mills, R. A. (2007), Resolution of primary acquired melanosis with atypia after minimal mitomycin C treatment. Clinical & Experimental Ophthalmology, 35: 865–867. doi: 10.1111/j.1442-9071.2007.01640.x
- Issue published online: 18 DEC 2007
- Article first published online: 18 DEC 2007
- Received 8 March 2007; accepted 6 September 2007.
- conjunctiva mitomycin C;
- primary acquired melanosis
The most effective dose of mitomycin C (MMC) in the treatment of primary acquired melanosis (PAM) with atypia of the conjunctiva and cornea has yet to be established. This case report describes successful treatment of PAM with atypia with a single four day cycle of 0.02% MMC.